Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.46
+0.03 (0.55%)
At close: May 1, 2026, 4:00 PM EDT
5.36
-0.10 (-1.83%)
After-hours: May 1, 2026, 5:15 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $119.12 million as of May 1, 2026. Its market cap has decreased by -27.47% in one year.
Market Cap
119.12M
Enterprise Value
9.53M
1-Year Change
-27.47%
Ranking
Category
Stock Price
$5.46
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $119.12M, a decrease of -65.19%. That is a compound annual growth rate of -58.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 119.12M | -58.32% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 129.56M |
| Kalaris Therapeutics | 125.19M |
| Genelux | 122.02M |
| PepGen | 120.95M |
| Cardiff Oncology | 116.91M |
| Vivani Medical | 115.12M |
| Seer, Inc. | 114.53M |
| Cognition Therapeutics | 114.37M |